Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria

No abstract is available for this paper.

• Publication year

  2011

• Venue

  British Journal of Surgery

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/bjs.7561PMID 21618496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Application of the Iliac Artery in the Ex Vivo Reconstruction of Renal Arteries in Renal Transplantation: Retraction.

  2019cited by this paper
• Liver Transplantation for Advanced Hepatocellular Carcinoma Using Poor Tumor Differentiation on Biopsy as an Exclusion Criterion

  2011cited by this paper
• Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas

  2011cited by this paper
• Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review.

  2011cited by this paper
• Current approach to hepatocellular carcinoma.

  2010cited by this paper
• Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

  2010cited by this paper
• Benefit of downsizing hepatocellular carcinoma in a liver transplant population

  2010cited by this paper
• Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target.

  2010cited by this paper
• Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: An intention‐to‐treat analysis

  2010cited by this paper
• The place of downstaging for hepatocellular carcinoma.

  2010cited by this paper
• Current approach in the treatment of hepatocellular carcinoma.

  2010cited by this paper
• Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma.

  2009cited by this paper
• Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China

  2009cited by this paper
• Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma

  2009cited by this paper
• Liberal selection criteria for liver transplantation for hepatocellular carcinoma

  2009cited by this paper
• Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation

  2009cited by this paper
• Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients.

  2009cited by this paper
• Factors affecting survival and tumor recurrence in patients transplanted for hepatocellular carcinoma and coexistent hepatitis C virus.

  2008cited by this paper
• Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma

  2008cited by this paper
• What is an intention to treat analysis?

  2008cited by this paper
• Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

  2008cited by this paper
• Excellent outcome following down‐staging of hepatocellular carcinoma prior to liver transplantation: An intention‐to‐treat analysis

  2008cited by this paper
• Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation

  2008cited by this paper
• Predictors of long‐term outcome following liver transplantation for hepatocellular carcinoma: a single‐center experience

  2007cited by this paper
• Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation

  2007cited by this paper
• Liver transplantation for hepatocellular carcinoma in Asia.

  2007cited by this paper
• Treatment of HCC in Patients Awaiting Liver Transplantation

  2007cited by this paper
• Intention‐to‐Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria

  2007cited by this paper
• Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be Expanded: A 22-Year Experience With 467 Patients at UCLA

  2007cited by this paper
• Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma

  2006cited by this paper
• Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis: Is Clinical Tumor Classification before Transplantation Realistic?

  2005cited by this paper
• A comparison of liver transplantation outcomes in the pre‐ vs. post‐MELD eras

  2005cited by this paper
• Predictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma

  2005cited by this paper
• Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C

  2004cited by this paper
• Grading quality of evidence and strength of recommendations

  2004cited by this paper
• Liver transplantation outcomes for early‐stage hepatocellular carcinoma: Results of a multicenter study

  2004cited by this paper
• Liver transplantation for hepatocellular carcinoma

  2004cited by this paper
• Consensus Statement

  2004cited by this paper
• Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

  2003cited by this paper
• Hepatocellular carcinoma: an epidemiologic view.

  2002cited by this paper
• Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival

  2001cited by this paper
• Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

  2001cited by this paper
• Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

  2001cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  1996cited by this paper
• Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients

  1993cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• Open Access Study Protocol a Prospective Randomised, Open-labeled, Trial Comparing Sirolimus-containing versus Mtor-inhibitor-free Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

  year unknowncited by this paper

• The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review

  2025cites this paper
• Unlocking the secrets of esophageal motility: how ineffective motility influences dysphagia and LES function following robotic hiatal hernia repair

  2025cites this paper
• EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma.

  2024cites this paper
• Influence of the Radiological Response on Histological Necrosis and on the Survival of Patients Treated With Transarterial Chemoembolization for Hepatocellular Carcinoma Secondary to Cirrhosis on the Liver Transplantation Waiting List.

  2024cites this paper
• The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes

  2023cites this paper
• Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution

  2023cites this paper
• Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation

  2022cites this paper
• Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia.

  2022cites this paper
• International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

  2021cites this paper
• Impact of metabolic indices of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma

  2021cites this paper
• Impact of locoregional therapy on post-transplant outcomes in patients with hepatocellular carcinoma beyond Milan criteria

  2021cites this paper
• Treatment for Hepatocellular Carcinoma in South Asia.

  2021cites this paper
• Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study

  2021cites this paper
• Radioembolization for Hepatocellular Carcinoma

  2021cites this paper
• Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis.

  2021cites this paper
• Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.

  2020cites this paper
• Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis

  2020cites this paper
• Liver transplantation and BCLC classification: Limitations impede optimum treatment.

  2020cites this paper
• The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?

  2020cites this paper
• Downstaging in patients with hepatocellular carcinoma: Is there real hope?

  2019cites this paper
• Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.

  2019cites this paper
• It is time to abandon the Milan criteria.

  2019cites this paper
• The Role of Radioembolization in Bridging and Downstaging Hepatocellular Carcinoma to Curative Therapy.

  2019cites this paper
• EVALUATION OF THE ANTIOXIDANT ACTIVITY OF FRUIT EXTRACTS OF INDIGENOUS MEDICINAL PLANT, ZIZYPHUS XYLOPYRUS (RETZ.) WILLD

  2018cites this paper
• The impact of transarterial chemoembolization induced complications on outcomes after liver transplantation: A propensity‐matched study

  2018cites this paper
• Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation

  2018cites this paper
• Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma

  2018cites this paper
• Liver Transplantation After Neoadjuvant Sorafenib Therapy: Preliminary Experience and Literature Review.

  2018cites this paper
• Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation.

  2017cites this paper
• Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.

  2017cites this paper
• Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.

  2017cites this paper
• Liver transplantation for hepatobiliary malignancies: a new era of “Transplant Oncology” has begun

  2017cites this paper
• Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.

  2016cites this paper
• Role of TACE in Patients with Hepatocellular Carcinoma before Liver Transplantation

  2016cites this paper
• Hepatitis B and Hepatocellular Carcinoma.

  2016cites this paper
• Current Treatment Approaches to HCC with a Special Consideration to Transplantation

  2016cites this paper
• A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma

  2016cites this paper
• Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model

  2016cites this paper
• New advances in hepatocellular carcinoma 2016 Hepatocellular Carcinoma : Global view

  2016cites this paper
• Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy

  2016cites this paper
• New advances in hepatocellular carcinoma.

  2016cites this paper
• Rapid Virological Response After Early Treatment with a Combined Therapy of Ledipasvir and Sofosbuvir in HCV Genotype 4 After Living Donor Liver Transplantation in a HCC Downstaged Patient: Case Report and Review of the Literature

  2016cites this paper
• LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA

  2016cites this paper
• Serum Alpha-Fetoprotein as a Biomarker in Liver Transplantation

  2016cites this paper
• Interventional radiology in the management of hepatopancreatobiliary malignancy and surgical complications

  2016cites this paper
• Recurrence of HCC When Transplanted Outside Milan Criteria

  2016cites this paper
• Hong Kong Consensus Recommendations on the Management of Hepatocellular Carcinoma

  2015cites this paper
• Chapter 60 – Ethics in Living Donor Transplantation

  2015cites this paper
• Radioembolization for hepatocellular carcinoma: current role and future directions - the medical oncologist's perspective.

  2015cites this paper
• Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient

  2015cites this paper
• Fabrication of galactosylated chitosan–5‐fluorouracil acetic acid based nanoparticles for controlled drug delivery

  2015cites this paper
• Surgical resection and liver transplantation for hepatocellular carcinoma.

  2015cites this paper
• Radioembolization for hepatocellular carcinoma: current role and future directions - the medical oncologist's

  2015cites this paper
• Advances in managing hepatocellular carcinoma

  2014cites this paper
• Response to locoregional treatment and alpha-fetoprotein trend in liver transplant candidates for HCC: dwarfs standing on the shoulders of giants.

  2014cites this paper
• Survival differences between Milan criteria after down-staging and De novo Milan in living donor liver transplantation for hepatocellular carcinoma.

  2014cites this paper
• Immediate Radical Therapy or Conservative Treatments When Meeting the Milan Criteria for Advanced HCC Patients After Successful TACE

  2014cites this paper
• Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.

  2014cites this paper
• Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma.

  2014cites this paper
• Reply to "Response to locoregional treatment and alpha-fetoprotein trend in liver transplant candidates for HCC: dwarfs standing on the shoulders of giants".

  2014cites this paper
• Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine

  2014cites this paper
• Hepatocellular carcinoma review: current treatment, and evidence-based medicine.

  2014cites this paper
• Prognostic factors for hepatocellular carcinoma recurrence.

  2014cites this paper
• Multimodality Therapy and Liver Transplantation for Hepatocellular Carcinoma: A 14-Year Prospective Analysis of Outcomes

  2014cites this paper
• Hepatitis B Virus: Epidemiology and Clinical Features of Related Cancer

  2014cites this paper
• Hepatitis Viruses: Hepatocellular Carcinoma

  2014cites this paper
• PREDICTING FACTORS OF RECURRENCE AFTER HCC TREATMENT Percutaneous

  2014cites this paper
• Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma

  2013cites this paper
• Hepatocellular Carcinoma: When to Transplant Outside of Milan Criteria

  2013cites this paper
• HCC. Radioembolization Combined with Other Therapeutic Local and Systemic Treatment

  2013cites this paper
• Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies

  2013cites this paper
• How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?

  2013cites this paper
• Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update.

  2013cites this paper
• Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

  2013cites this paper
• Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.

  2013cites this paper
• Pathologic response to non-surgical locoregional therapies as potential selection criteria for liver transplantation for hepatocellular carcinoma.

  2013cites this paper
• Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria

  2013cites this paper
• Milan Criteria, Multi-nodularity, and Microvascular Invasion Predict the Recurrence Patterns of Hepatocellular Carcinoma After Resection

  2013influential citation
• Liver Transplantation: An Appraisal of the Present Situation

  2013cites this paper
• Impact of tumor size, number of tumors and neutrophil‐to‐lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma

  2013cites this paper
• Laparoscopic approach for down-staging in hepatocellular carcinoma patients who are candidates for liver transplantation.

  2013cites this paper
• Hepatocellular carcinoma resection post-selective internal radiation therapy

  2012cites this paper
• Role of Operative Therapy in Non-cirrhotic Patients with Metastatic Hepatocellular Carcinoma

  2012cites this paper
• Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

  2012cites this paper
• Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.

  2012cites this paper
• New concepts and best practices for management of pre- and post-transplantation cancer.

  2012cites this paper
• Comparing Outcomes for Rare Primary Hepatic Tumors after Liver

  2011cites this paper
• Pushing the limits of surgical management in patients with hepatocellular carcinoma

  2011cites this paper
• Liver Transplantation for Hepatocellular Carcinoma

  2008cites this paper